InvestorsHub Logo
Followers 27
Posts 1791
Boards Moderated 0
Alias Born 10/17/2010

Re: rustydog62 post# 8729

Thursday, 04/08/2021 10:53:07 AM

Thursday, April 08, 2021 10:53:07 AM

Post# of 9558
A statement issued 2 years ago...

“Our proprietary technologies and methods employ magnetic nanoparticles targeted toward cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors. We are in collaboration with Global Cancer Technology and their scientists to explore their very promising drug delivery technology. We envision a nanotechnology platform that would deliver both our proprietary imaging capabilities along with the targeted therapeutic capabilities that GCT provides. With a successful collaboration physicians, for the first time, would be able to image and treat a tumor using a single nanotechnology delivery medium.”
Robert Prouix
President & CEO, Imagion Biosystems Inc